The Biden Administration and Congress established the Advanced Research Projects Agency for Health (ARPA-H) to accelerate biomedical research and deliver health breakthroughs for all patients. The decision of where to headquarter the first federal agency dedicated to accelerating health innovations has not yet been made.
President Biden proposed the creation of the Advanced Research Projects Agency for Health (ARPA-H) to improve the U.S. government’s ability to speed biomedical and health research. Public Law 117-103 was enacted on March 15, 2022, authorizing the establishment of ARPA-H within the U.S. Department of Health and Human Services.
1. To push the limits of biomedical and health research to diagnose and cure major diseases (including cancer, heart disease, diabetes, Alzheimer’s disease, and infectious diseases).
2. To ensure that medical breakthroughs are accessible and maximally benefit the American people, especially those who are disproportionally affected by health inequities.
3. To work with global partners to solve our global and national health care challenges since disease and pathogens know no geographic boundaries.
“If headquartered in Georgia, ARPA-H would be championed and embraced by our world-class talent, dynamic commercial technology sector, and rich public health research legacy. We believe Georgia’s institutions provide the best partners for ARPA-H to push the limits of biomedical and health research, ensure accessibility of medical breakthroughs, and engage global partners.” -Georgia Congressional delegation letter, June 21, 2022
Russell Medford, MD, PhD (Chair, AGC); Chair and CEO, Covanos, Inc.; Chair, Board of Directors, Center for Global Health Innovation
Maria Thacker-Goethe, CEO
Deborah Bruner, RN, PhD FAAN, SVP of Research
H. Lee Herron, DVM, VP, Venture Development
Chaouki T. Abdallah, MS, PhD, EVP of Research
Tim Denning, PhD, Vice President for Research & Economic Development
Leanna K. Brown, VP Business Climate & Talent Dev
David Hartnett, Chief Economic Development Officer
Jean R. Sumner, BSN, MSN, MD, Dean of School of Medicine
James Lillard, PhD, Senior Associate Dean
David A. Ross, ScD, President and CEO
Clark Dean, Executive Managing Director
Sheila P. Burke, Senior Public Policy Advisor
Rob Gardner, Public Policy Advisor
Linda A. Klein, JD, Partner
Michelle Williams, JD, Partner
The Center for Global Health Innovation’s mission is to advance global and national health equity by promoting and facilitating partnerships to drive impactful innovation. By acting as a trusted convener, we strive to be an action-oriented community change agent and convene for a purpose to move people and communities forward on some of their most intractable issues.